Clinical Trials
24 trialsNovel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Shandong Cancer Hospital and Institute
CIME
Centre Leon Berard
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
Bristol-Myers Squibb
Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
Tang-Du Hospital
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer
Tang-Du Hospital
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Chinese University of Hong Kong
New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
Tang-Du Hospital
NICE
Nanfang Hospital, Southern Medical University
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
Fudan University
ARMANI
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Seoul National University Hospital
Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer
Samsung Medical Center
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
Shanghai Zhongshan Hospital
XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Anhui Provincial Hospital
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor
Sun Yat-sen University
XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma
Tianjin Medical University Cancer Institute and Hospital
EHTLAGCRGD2
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients
Tianjin Medical University Cancer Institute and Hospital
GASTRANOX
Thrombosis Research Institute
XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)
Dong-A University Hospital